Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis

समान संसाधन

• Biologics and Biosimilars as Treatment Options for Psoriasis
  द्वारा: Moya, Amena Khatun
  प्रकाशित: (2023)
• Importance of biologics in rheumatoid arthritis management
  द्वारा: Riyadh, S. M.
  प्रकाशित: (2022)
• TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
  द्वारा: Afroza, Halima
  प्रकाशित: (2024)
• Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
  द्वारा: Mehreen, Elnaj
  प्रकाशित: (2021)
• A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
  द्वारा: Islam, Nahidul
  प्रकाशित: (2023)